Pituch-Noworolska A, Gawlicka M
Zakładu Immunologii Klinicznej i Mikrobiologii, Polsko-Amerykańskiego Instytutu Pediatrii, Krakowie.
Acta Haematol Pol. 1993;24(4):365-71.
The DNA profile of blast cells was assayed in 61 children with acute leukemias (51 patients) and non-Hodgkins lymphomas (NHL--10 patients). The value of S phase (synthesis of DNA) and G2M phase (mitotic stage) was compared between the subtypes of acute leukemia and lymphoma based on blast cell phenotype. In acute lymphoblastic leukemia (ALL) the lowest S phase of blast cells was seen in null-ALL subtype, the highest in T-ALL. In non-lymphoblastic leukemia (ANLL) the value of S phase was below S phase observed in ALL. B cell NHL showed higher S phase as compared to T-lymphocyte derived NHL cells. Aneuploidy was noted as hyperdiploidy (8 cases), hypodiploidy (4 cases) and two leukemia cell lines (3 ALL patients). The DNA profile as marker of proliferative activity of blastic cells provides an important information associated with the prognosis of patient.
对61例急性白血病患儿(51例)和非霍奇金淋巴瘤(NHL——10例)的原始细胞进行了DNA分析。根据原始细胞表型,比较了急性白血病和淋巴瘤各亚型之间S期(DNA合成期)和G2M期(有丝分裂期)的值。在急性淋巴细胞白血病(ALL)中,原始细胞的最低S期见于无标记ALL亚型,最高见于T-ALL。在非淋巴细胞白血病(ANLL)中,S期值低于ALL中观察到的S期。与T淋巴细胞来源的NHL细胞相比,B细胞NHL显示出更高的S期。非整倍体表现为超二倍体(8例)、亚二倍体(4例)和两条白血病细胞系(3例ALL患者)。作为原始细胞增殖活性标志物的DNA分析提供了与患者预后相关的重要信息。